SEARCH RESULT

Total Matching Records found : 40

The enigma of Indian engineering-James Trevelyan

A narrow education is making engineers oblivious to the importance of human interaction and raising the cost of even simple tasks My time in South Asia has rewarded me with an enigma: why is engineering so expensive here? Why is it often many times more expensive than in Australia, my home? My search for answers led me to shanty towns on the fringes of mega-cities. We compared an award winning Indian factory...

More »

India's proposal will help take the web out of U.S. control-Parminder Jeet Singh

-The Hindu Unnerved by the Indian stand, IT monopolies are propagating the myth that a multilateral governance structure will kill the decentralised, multi-stakeholder nature of the Internet and lead to ‘government control' Last year, in a statement to the U.N. General Assembly, India sought the creation of a U.N. Committee on Internet-Related Policies (CIRP) in order to democratise global Internet governance, which at present is either U.S.-controlled, or subject to the policies...

More »

Question of efficacy -Leena Menghaney

The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...

More »

A welcome first -TK Rajalakshmi

Industry reacts with caution to the grant of a compulsory licence to Natco, but cancer patients welcome it and hope for many more. THE first compulsory licence (CL) issued by the Indian patent office, to the local drug manufacturer Natco Pharma Ltd to sell the generic version of Bayer AG's anti-cancer drug Nexavar, has led to varied reactions. The landmark decision has also raised concerns about the outcome of cases...

More »

Patent to plunder -Amit Sengupta

India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close